Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study

Coates, L, Mease, P, Gladman, D et al. (8 more authors) (2020) Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020.

Metadata

Authors/Creators:
  • Coates, L
  • Mease, P
  • Gladman, D
  • Van den Bosch, F
  • Rychlewska-Hanczewska, A
  • Tasset, C
  • Meuleners, L
  • Trivedi, M
  • Guo, Y
  • Besuyen, R
  • Helliwell, P
Dates:
  • Published: 1 July 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Jan 2021 10:45
Last Modified: 05 Jan 2021 10:45
Status: Published
Identification Number: https://doi.org/10.1093/rheumatology/keaa111.214
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)